Revenue segments as reported by the company.

Net revenue, before excise taxes

Excise taxes

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Sales and marketing

Research and development

General and administrative

Restructuring costs

Share-based payments

Depreciation and amortization

Impairment loss on goodwill and indefinite-lived intangible assets

Impairment loss on long-lived assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cronos Group

Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones, and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cronos Group, Inc. engages in the production and distribution of cannabis. I It operates through the Canada and Israel segments. The company was founded on August 21, 2012 and is headquartered in Toronto, Canada.

HEXO Corp

OrganiGram Holdings Inc.

Jefferies upgraded two Canadian cannabis stocks on Thursday and reduced his price target on a third, remaining most bullish on buy-rated OrganiGram Holdings Inc., which it said is “really starting to hit its stride.”

Cannabis Watch: Jefferies issues bullish note on buy-rated OrganiGram, upgrades Cronos and Hexo and cuts Tilray's price target

Aurora Cannabis

Canopy Growth

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

Altria

Constellation Brands

Trulieve Cannabis Corp.

While the U.S. pot growers had an amazing 2021, dark clouds loomed over their Canadian counterparts.

Canadian Pot Stocks Had a Disappointing Year. Will 2022 Be Better?

Canadian cannabis company Cronos Group (NASDAQ:CRON) promoted John Griese, former chief operating officer of The Supreme Cannabis Co., as senior vice president, head of North American operations, reported Marijuana Business Daily. The Toronto-headquartered company provided no official press release on the management change, though the move was reported in a regulatory filing last week.

Cronos Promotes John Griese, Former Exec At Nestlé, PepsiCo And Supreme Cannabis

SNDL Inc.

Despite marijuana being a fast-growing industry, these cannabis stocks are buzzkills.

4 Pot Stocks to Avoid Like the Plague in 2022

NewLake Capital Partners, Inc.

Turning Point Brands

Whether federal reform happens in 2022, or if it gets delayed once more, pot plays could still become smoking hot again throughout this year. Here are seven marijuana stocks, all of which may be set to experience high times.

7 Marijuana Stocks to Buy Today for Blazing Profits

The marijuana sector is full of exciting stocks, but these two should be avoided.

2 Pot Stocks To Flat Out Avoid in 2022

BTCS

Hive Blockchain Technologies Ltd

Hecla Mining

ObsEva

Transocean

Electrameccanica

These penny stocks look poised for a rally in January 2022 and can possibly deliver multi-fold returns in the next 12 months. The post 7 Penny Stocks to Buy for January appeared first on InvestorPlace.

7 Penny Stocks to Buy for January

The company delayed the release of an SEC filing and got dragged down by the broad downturn in cannabis stocks.

Why Cronos Group Stock Slumped 14% in December

Tilray Brands

Best Canadian Pot Stocks For January 2022 The post Best Canadian Marijuana Stocks For Your January 2022 Watchlist Right Now appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Best Canadian Marijuana Stocks For Your January 2022 Watchlist Right Now

New York, New York--(Newsfile Corp. - December 30, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of Cronos Group Inc. (NASDAQ: CRON) resulting from allegations that Cronos may have issued materially misleading business information to the investing public.SO WHAT: If you purchased Cronos securities you may be entitled to compensation without payment of any out of pocket fees or costs...

Rosen, a Highly Recognized Law Firm, Encourages Cronos Group Inc. Investors with Losses to Inquire About Class Action Investigation - CRON

This article by Johnny Green was originally published on Cannabis & Tech Today, and appears here with permission. The cost of cannabis flower has fluctuated throughout the years.

Cheap Weed: How Low Will Cannabis Prices Go In The Future?

Innovative Industrial Properties

Stocks like Cronos Group (CRON), Canopy Growth (CGC) and Innovative Industrial Properties (IIPR) are sure to benefit at present amid the cannabis legalization wave.

Ride The Cannabis Legalization Wave With These 3 Stocks

Canadian Pot Stocks For Your 2022 Watchlist The post Canadian Marijuana Stocks To Watch Before January 2022 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Canadian Marijuana Stocks To Watch Before January 2022

3 Canadian Marijuana Stocks To Watch In 2022 The post 3 Canadian Marijuana Stocks To Watch Before The Start Of 2022 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

3 Canadian Marijuana Stocks To Watch Before The Start Of 2022

You can still get in on the ground floor of the marijuana market, which will only get hotter as more states and countries move toward legalization. Ben Rains shows several ways to invest before the floodgates open.

Big Marijuana Stock Profits in Surprising Places

NEW YORK, Dec. 19, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of Cronos Group Inc. (NASDAQ: CRON) resulting from allegations that Cronos may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Cronos securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

ROSEN, A TOP RANKED LAW FIRM, Encourages Cronos Group Inc. Investors with Losses to Inquire About Class Action Investigation - CRON

22nd Century Group

Canadian marijuana titan Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB) together with 22nd Century Group, Inc. (NASDAQ:XXII) will license biosynthesis intellectual property to Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON). The licensed intellectual property is designed to help advance the research and development of the biosynthesis of cannabinoids.

Aurora Cannabis, 22nd Century Group To License Biosynthesis Intellectual Property To Cronos

Apple

Chevron

Intel

Lockheed Martin

Target

Going overweight on low-beta, high-dividend stocks helps make your portfolio defensive. Here are seven well-known names that stand out from the crowd.

7 Big Dividend Paying Stocks to Hold Forever

Licensing deal set to assist in the advancement of research and development for cannabinoid biosynthesis EDMONTON, AB, Dec. 14, 2021 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) ("Aurora"), the Canadian company defining the future of cannabinoids worldwide, together with 22nd Century Group, Inc. (NASDAQ: XXII) ("22nd Century") announced today a three-way non-exclusive agreement to license biosynthesis intellectual property to Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group"), intended to assist in the advancement of research and development on the biosynthesis of cannabinoids. Biosynthesis, a process common in the pharmaceutical industry, involves using living micro-organisms to convert simple substances into complex compounds.

Aurora and 22nd Century Group License Foundational Biosynthesis IP to Cronos Group

Top Canadian Marijuana Stocks To Buy? Are These Right For You The post Will You Buy These Canadian Marijuana Stocks In 2022? Here's What To Know appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Will You Buy These Canadian Marijuana Stocks In 2022? Here's What To Know

New York, New York--(Newsfile Corp. - December 7, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of Cronos Group Inc. (NASDAQ: CRON) resulting from allegations that Cronos may have issued materially misleading business information to the investing public.SO WHAT: If you purchased Cronos securities you may be entitled to compensation without payment of any out of pocket fees or...

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Cronos Group Inc. Investors with Losses to Inquire About Class Action Investigation - CRON

NEW YORK, Dec. 4, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Cronos Group Inc. (NASDAQ: CRON) resulting from allegations that Cronos may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Cronos securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

CRON INVESTOR NOTICE: ROSEN, A LEADING NATIONAL FIRM, Encourages Cronos Group Inc. Investors with Losses to Inquire About Class Action Investigation - CRON

Los Angeles, California--(Newsfile Corp. - December 3, 2021) -  The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cronos Group Inc. ("Cronos" or "the Company") (NASDAQ: CRON) for violations of the securities laws.The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Cronos filed a Form 8-K with the SEC on November 9,...

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Cronos Group Inc. and Encourages Investors with Losses to Contact the Firm

OAKLAND, Calif.--(BUSINESS WIRE)---- $CRON #CRON--Shares of Cronos Group plummeted more than 15% on November 9, 2021, after the company announced in an SEC filing that it should have taken an impairment charge of at least $220 million, and that the company would be required to restate its financial statements for three and six months ending June 30, 2021. Gibbs Law Group continues to investigate a potential Cronos Securities Class Action Lawsuit on behalf of investors who lost money in Cronos (NASDAQ: CRON). T

Lost Money in Cronos Group, Inc?

AFC Gamma

Agrify

Arena Pharmaceuticals

Alpine Global Premier Properties Fund

Cambria Global Real Estate ETF

Clever Leaves Holdings Inc

Amplify Seymour Cannabis ETF

Cardiol Therapeutics

Charlotte's Web Holdings, Inc.

Direxion Daily CSI China Internet Index Bull 2X Shares

WisdomTree Global ex-US Real Estate Fund

Invesco S&P 500 Equal Weight Real Estate ETF

First Trust FTSE EPRA/NAREIT Developed Markets Real Estate

Fidelity MSCI Real Estate ETF

First Trust S&P REIT Index Fund

Greenlane Holdings

FlexShares Global Quality Real Estate Index Fund

GrowGeneration Corp

Xtrackers International Real Estate ETF

High Tide

Hydrofarm Holdings Group

High on Growth: Cannabis REITs are far-and-away the best-performing REIT sector of the past half-decade as the budding industry thrives in the murky and often contradictory regulatory framework of legalized marijuana. Joining Innovative Industrial, Power REIT, and AFC Gamma, a pair of newcomers will soon enter the pot party - Chicago Atlantic Real Estate Finance and Freehold Properties - both operating as mortgage REITs.

Cannabis REITs: When They Go Low, We Get High

News for Cronos Group Stock (CRON)